热门资讯> 正文
生物技术公司Scorpius上半年收入增长三倍，获得1，440万美元融资
2024-08-26 21:19
- Biotech company Scorpius Holdings (NYSE:SCPX) CEO Jeff Wolf said on Monday in a letter to shareholders that the company has recorded a threefold increase in revenue for the first half of 2024.
- Scorpius’ current sales pipeline now includes more than $100M in opportunities across the biopharmaceutical and government sectors.
- The company has recently completed a round of financing, raising about $14.4M in gross proceeds, Wolf added in his letter.
- The funds will help Scorpius to provide better services and attract customers, enabling the biotech company to diversify its customer base with both commercial and government opportunities.
- The company has also started transitioning several of its key clients from process development phase into full-scale manufacturing to enable additional revenue stream.
- Shares of Scorpius were down 3.33% during pre-market trading.
More on Scorpius Holdings
- Financial information for Scorpius Holdings
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
